News

Dr Dannel Yeo from the Centenary Institute and Clinical Associate Professor Kate Mahon from Chris O’Brien Lifehouse, have been awarded an inaugural Sydney Cancer Partners Translational Fellowship.

Professor John Rasko AO, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute has featured on the popular Radio National show Sunday Extra in the segment called ‘The Year That Made Me’.

Professor John Rasko AO and team have received the top scoring abstract award at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders in Manchester.

The Centenary Institute has celebrated the publication of a new book, 'The Good Gut Anti-Inflammatory Diet’ at a special event, held at the Dymocks Bookstore, Sydney.

This International Day of Women and Girls in Science, we profile Emma Singer, a PhD student and Research Assistant in the Centenary Institute’s Bioinformatics and Molecular Genetics Laboratory.

The Centenary Institute has highlighted its critical research into the biology of ageing – aimed at improving the quality of life for older people – at the 2023 NSW Seniors Festival Expo, held at the International Convention Centre, Darling Harbour, Sydney.

The Centenary Institute is delighted to announce that Professor Marc Pellegrini will join the Centenary Institute as its new Executive Director. A physician, immunologist and internationally renowned research scientist, Professor Pellegrini has over 20 years of experience working on chronic infections.

Seven researchers from the Centenary Institute have been listed among the global top two percent of scientists in their fields – according to a recently published Stanford University study.

A new book, ‘The Good Gut Anti-Inflammatory Diet’, has been released by the Centenary Institute, which is full of informative knowledge, recipes and advice to maintain good gut health to control inflammation and to help prevent disease.

As we age our cells also age. They lose their normal functions and become resistant to cell death.

Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD) – the targeting and inhibition of a protein called RIPK1.

Research led by the Centenary Institute and the University of Sydney – focused on the development of a new nasal COVID-19 vaccine – has received close to $1m in grant funding from the NSW COVID-19 Vaccine Acceleration Research Grants Program.